Sort
64,565 grants matching “drug discovery”
Development of a novel Alzheimer's disease therapeutic targeting tau
$998,691Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2025 · AG
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
$998,661Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2022 · AI
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
$998,661Steven Joseph Darnell · Dnastar, Inc. · R44 · FY2021 · AI
Pacific Northwest Advanced Compound Identification Core
$998,631Thomas O Metz · Battelle Pacific Northwest Laboratories · U2C · FY2019 · ES
Gulf Coast Consortia (GCC) Research Evaluation and Commercialization Hub
$998,317Peter J Davies · Texas A&M University Health Science Ctr · U01 · FY2025 · GM
A 3D vascularized islet biomimetic to model type 1 diabetes
$998,312Maike Sander · University Of California, San Diego · UH3 · FY2023 · DK
SBIR Phase II: Fluorescent Polymeric Nanoparticles
$998,241Lawrence F Hancock · Nomadics, Inc · · FY2003 · TIP
UC BRAID Center for Accelerated Innovation
$998,230Michael J Palazzolo · University Of California Los Angeles · U54 · FY2019 · HL
Amish Connectome Project on Mental Illness
$998,092L. Elliot Hong · University Of Maryland Baltimore · U01 · FY2016 · MH
Depletion of Dendritic Cells by Immunotoxin as Therapy for Myocardial Infarction
$998,051Michael W Fanger · Celdara Medical, Llc · R44 · FY2013 · HL
MetaboQuest: A Suite of Tools for Metabolite Annotation
$997,931Dawit Mengistu · Omicscraft, Llc · R44 · FY2023 · GM
MetaboQuest: A Suite of Tools for Metabolite Annotation
$997,931Dawit Mengistu · Omicscraft, Llc · R44 · FY2022 · GM
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
$997,899Wu-Bo Li · Functional Genetics, Inc. · R44 · FY2012 · AI
Novel small-molecule therapies for CF
$997,891Alan S Verkman · University Of California, San Francisco · P30 · FY2007 · DK
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$997,875Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R44 · FY2023 · AI
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2025 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2023 · CA
SBIR Phase II: A novel 3D bioprinting system for rapid high-throughput tissue fabrication
$997,692Wei Zhu · Allegro 3d, Inc · · FY2021 · TIP
Inhibition Of Renal Injury
$997,543Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies
$997,500Wenyi Wei · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA
Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models
$997,451Sergey A Ermilov · Photosound Technologies, Inc. · R44 · FY2022 · OD
Defining T cell epitopes in Dengue virus infection
$997,328Ramila Philip · Immunotope, Inc. · R44 · FY2014 · AI
Developmental Funds
$997,121Stanton L Gerson · Case Western Reserve University · P30 · FY2020 · CA
Targeting superbugs: discovery and development of new broad-spectrum lipopeptides
$996,973Jian Li · Monash University · R01 · FY2016 · AI
Development of Hepatitis C Virus Inhibitors
$996,920Progenics Pharmaceuticals, Inc. · R44 · FY2005 · AI